SEP
WST icon

Signature Equity Partners’s West Pharmaceutical WST Stock Holding History

Signature Equity Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.16K Sell
17
-1
-6% -$306 ﹤0.01% 945
2026
Q1 		$4.56K Sell
18
-4
-18% -$995 ﹤0.01% 983
2025
Q4 		$6.1K Buy
+22
New +$6.02K ﹤0.01% 942

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Signature Equity Partners's WST Position: Q2 2026 in Review

Signature Equity Partners reduced its West Pharmaceutical (WST) stake by 5.6% in Q2 2026, selling an estimated $306 and leaving 17 shares worth $6.16K. The position accounts for ﹤0.01% of the portfolio, ranked #945.

Signature Equity Partners first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Signature Equity Partners held 17 shares of West Pharmaceutical worth $6.16K as of Q2 2026.
  • Signature Equity Partners sold 1 West Pharmaceutical share in Q2 2026, an estimated $306.
  • West Pharmaceutical made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #945 holding.
  • Signature Equity Partners first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.